Contact Us
Web Copyright: Shijiazhuang No.4 Pharmaceutical Co., Ltd. Powered by www.300.cn 冀ICP备05007979号-1
Add: No. 288,Zhujiang Road, High-tech Industrial
Development,Shijiazhuang, Hebei, China
Web: www.sjzsiyao.com
Tel: 86 311 67167137 / 67167144
E-mail: trade@sjzsiyao.com / chinainfusion@163.com
Skype: xlmamary
About Us
Contact us!
Online Message
products
Product name:Anbroxol Hydrochloride orally Disintegrating Tables
Product name:Anbroxol Hydrochloride orally Disintegrating Tables
Specification:Tables
Usage and Dosage:
Take orally, this product is placed on the surface of the tongue, no need to chew, disintegrate quickly, swallow with saliva into the stomach, 1-2 tablets once, three times a day, take after meals
Formulation:
The main ingredient is Ambroxol hydrochloride, the excipients are: stearic acid, mannitol, microcrystalline cellulose, low substituted hydroxypropyl cellulose, sucralose, citric acid, sodium bicarbonate, sodium dodecyl sulfate, sunset yellow color, powder flavor, magnesium stearate.
Indication:
This product is ideal for expectorant and lung infection prevention and protection, reducing the viscosity of sputum and strengthening the outward movement of sputum; it is fast disintegrating and easy to take without water, more suitable for patients with swallowing difficulties. Oral disintegration tablet is a new drug dosage form, which can be rapidly dissolved in saliva and other aqueous delivery, and can be quickly melted by saliva after being put into the mouth, making it easy for patients, especially pediatric patients and patients with swallowing difficulties and elderly patients with water shortage conditions, to take. It can greatly improve the compliance of pediatric patients and solve the problem of difficulty in taking medication for infants and children, as well as improve the quality of life for general patients. Long-term amiloride expectorant therapy can help improve clinical symptoms in patients with severe chronic obstructive pulmonary disease; amiloride can also benefit patients with acute exacerbation of chronic obstructive pulmonary disease by modulating oxidative stress.